ARCHIVES

House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992

NCAB Asks NCI To Delay Proposed change In Breast Cancer Screening Guidelines

November 26, 1993

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976